藥物釋放式經皮冠狀動脈腔內成形術導管
PMA 核准號：P230035 · 2026-08-28
廣告
器材摘要
Drug-eluting percutaneous transluminal coronary angioplasty catheter is the device name listed in this FDA 510(k) record. The listed applicant is Boston Scientific Corporation. It received FDA 510(k) clearance on 2026-08-28. The device is classified under product code OOB. It was reviewed by the CV advisory panel.
常見問題
What is the Drug-eluting percutaneous transluminal coronary angioplasty catheter?
Drug-eluting percutaneous transluminal coronary angioplasty catheter is a medical device that received FDA 510(k) clearance on 2026-08-28. The listed applicant is Boston Scientific Corporation.
When did Drug-eluting percutaneous transluminal coronary angioplasty catheter receive FDA 510(k) clearance?
The clearance date for Drug-eluting percutaneous transluminal coronary angioplasty catheter can be found in the official FDA records.
誰是藥物滲透經皮冠狀動脈腔內成形術導管之登記申請人？
FDA 510(k) 記錄中將波士頓科學公司列為申請人。這並不單獨確立設備製造商。
FDA藥物滲透經皮冠狀動脈腔內成形術導管之產品代碼是什麼？
FDA 藥物滲透經皮冠狀動脈腔內成形術導管之產品代碼為 OOB。
相關臨床試驗
相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。
官方來源
在 FDA 資料庫中查看 →資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。
廣告